Momelotinib Oral Presentation at European Hematology Association Demonstrates Association Between Transfusion Independence and Improved Overall Survival

SAN MATEO, Calif.: —Additional poster presentation highlights improved transfusion independence of momelotinib irrespective of baseline degree of anemia, platelet count or transfusion status— SAN MATEO, Calif., June 11, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms...

Click to view original post